Intellia Therapeutics, Inc. which can be found using ticker (NTLA) have now 26 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 154 and 44 suggesting an average Analsyt target price of $91.35. Given that the stocks previous close was at $42.02 this would imply there is now a potential upside of 117.4%. The 50 day moving average now sits at $39.12 while the 200 day moving average is $46.20. The market cap for the company is 3.91B. The stock price for Skyline Champion Corporation is 44.39 USD
The potential market cap would be $8,505,808,540 based on the market consensus.
USD
The company has a dividend yield of 2.49%. Other points of data to note are a P/E ratio of -, revenue per share of 0.67 and a -20.31% return on assets.
